Obesity Medicine Doctor Explains Retatrutide: New Weight Loss Drug In Trials
Retatrutide is the experimental weight loss medication turning heads in clinical trials right now, with Phase 3 results showing nearly 29% average weight loss, the highest ever reported for an obesity drug. In this video, Dr. Bazgha Khalid breaks down exactly what retatrutide is, how its unique triple hormone mechanism works, the real clinical trial data behind the headlines, benefits beyond the scale, what people are already getting wrong about it, and a realistic timeline for when it might actually be approved. No hype, just the real science explained simply.
This video is for general education and is not a substitute for personal medical advice. Retatrutide is investigational and not yet FDA approved. Always talk to your own doctor about your individual treatment options.
#Retatrutide #GLP1 #WeightLossDrugs #ObesityMedicine #Ozempic #Zepbound #Tirzepatide #Semaglutide #WeightLossJourney #MetabolicHealth #EliLilly #NewWeightLossMedication #HealthEducation #DoctorExplains #WeightLossPipeline
